← The SEC Ephemeris: the whole map
SQ Innovation, Inc. furosemide
In the graph: all 1 documents (2 pages).
- Application
- NDA 217294
- Ticker
- SQ Innovation, Inc.
- Product
- furosemide
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- January 12, 2024
From FDA letters and SEC filings. Not investment or medical advice.